Protection of mice from experimental infection with type III group B Streptococcus using monoclonal antibodies

doi:10.1084/jem.158.3.1006

This Article

	Full Text (PDF, 563K)
	Alert me when this article is cited

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Egan, M. L.
	Articles by Gray, B. M.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Egan, M. L.
	Articles by Gray, B. M.


Social Bookmarking

	What's this?

ARTICLES

Protection of mice from experimental infection with type III group B Streptococcus using monoclonal antibodies

ML Egan, DG Pritchard, HC Dillon Jr and BM Gray

Mouse hybridoma antibodies of several major classes against group B streptococcus type III have been produced. Mice were immunized with either whole heat-killed or acid-treated organisms to obtain antibodies against both the complete (sialated) or incomplete (nonsialated) forms of the type III polysaccharide. Resulting monoclonal antibodies showed exclusive specificity for either the complete or incomplete antigen. The ability of these antibodies to protect mice from a lethal challenge of live type III organisms was tested with a mucin model that permitted use of very small inocula given intraperitoneally with antibody and mucin. Antibodies specific for the nonsialated antigen were not protective, whether of IgM, IgG2a, or IgG3 isotypes. Antibodies specific for the complete antigen were, however, highly protective, including monoclonals of IgM, IgG2a, and IgA isotypes. These mouse monoclonal antibodies against group B streptococci that are directed against either complete or incomplete antigenic determinants, and include isotypes other than IgM, should be particularly useful for studying the mechanism of protection against experimental infection.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Muthukkumar, S., Goldstein, J., Stein, K. E. (2000). The Ability of B Cells and Dendritic Cells to Present Antigen Increases During Ontogeny. J. Immunol. 165: 4803-4813 [Abstract] [Full Text]
Takahashi, S., Aoyagi, Y., Adderson, E. E., Okuwaki, Y., Bohnsack, J. F. (1999). Capsular Sialic Acid Limits C5a Production on Type III Group B Streptococci. Infect. Immun. 67: 1866-1870 [Abstract] [Full Text]
Pincus, S. H., Smith, M. J., Jennings, H. J., Burritt, J. B., Glee, P. M. (1998). Peptides That Mimic the Group B Streptococcal Type III Capsular Polysaccharide Antigen. J. Immunol. 160: 293-298 [Abstract] [Full Text]